Important drug information: Immune globulin intravenous (human)

Jay S. Epstein, Frederick Varricchio(Rutgers, The State University of New Jersey), Ross Pierce(Center for Biologics Evaluation and Research), Richard Potter(Center for Biologics Evaluation and Research), Richard Kapit(Center for Biologics Evaluation and Research), Ann Gaines(Center for Biologics Evaluation and Research)
International Journal of Trauma Nursing
October 1, 1999
10.1016/s1075-4210(99)90011-1
Cited by 4

Related Papers

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System
|The Pediatric Infectious Disease Journal|2004|381
Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation
|Vaccine|2003|243
Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma.
|PubMed|2000|226
Active Exercise, Education, and Cognitive Behavioral Therapy for Persistent Disabling Low Back Pain
|Spine|2007|203
The Vaccine Adverse Event Reporting System
|Journal of Toxicology Clinical Toxicology|1998|135